Coding for COVID-19 Immunizations

June 11, 2021

ACOG representatives to the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel are working with vaccine developers and other physician societies to create vaccine and immunization administration codes for the COVID-19 vaccine as they submit Emergency Use Authorization (EUA) applications to the Federal Food and Drug Administration (FDA). 

The AMA CPT Editorial Panel has approved the following codes: 

Pfizer-BioNTech COVID-19 Vaccine (NCD 10/NCD 11: 59267-1000-1; 59267-1000-01) CPT 91300
Vaccine Administration

  • 1st Dose: 0001A
  • 2nd Dose: 0002A

Moderna COVID-19 Vaccine (NCD 10/NCD 11: 80777-273-10; 80777-0273-10) CPT 91301
Vaccine Administration

  • 1st Dose: 0011A
  • 2nd Dose: 0012A

AstraZeneca COVID-19 Vaccine (NCD 10/NCD 11: 0310-1222-10; 00310-1222-10) CPT 91302
Vaccine Administration

  • 1st Dose: 0021A
  • 2nd Dose: 0022A

Janssen COVID-19 Vaccine (NCD 10/NCD 11: 59676-580-05; 59676-0580-05) CPT 91303
Vaccine Administration

  • 1st Dose: 0031A Single dose

As more vaccines and codes are approved, this table will be updated. 

Insurance coverage of COVID-19 Vaccines

The federal government is supplying the vaccines for distribution to facilities and practices that are enrolled as Medicare providers or COVID-19 immunization administrators. Enrollment allows the facility or practice to bill for the administration of the vaccine using the Vaccine Administration codes above. Reimbursement is geographically adjusted and based on the national payment rate. Starting on March 15, 2021, Medicare will pay approximately $40 for each dose in the vaccination series.

The Centers for Medicare & Medicaid Services (CMS) is offering a provisional enrollment for facilities and providers who are not currently enrolled but would like to become a COVID-19 immunization administrator. An abbreviated enrollment process includes a quick call to the regional Medicare Administrative Contractor.

Please have available the following: 

  • Legal Business Name (LBN) 
  • National Provider Identifier (NPI) 
  • Tax Identification Number (TIN) 
  • Practice location 
  • State license (if applicable)

In June 2021, CMS announced the option for an additional payment for administering the COVID-19 vaccination in-home to Medicare beneficiaries. This was done in the hopes of reaching Medicare patients who have difficulty leaving their homes or are otherwise hard-to-reach. Providers can bill for this service utilizing the new HCPCS code M0201 for COVID-19 vaccine administration. This is to be used in conjunction with the appropriate CPT code for COVID-19 vaccine product and dose and can only be utilized if vaccination is the sole reason for the in-home patient visit. If more than one patient is being vaccinated at the same in-home visit, providers should bill the HCPCS code M0201 only once and bill additional CPT product/dose codes as necessary. Billing for in-home administration should be done only once per date, per service.

All Medicare patients are covered through the fee-for-service program, even if they are enrolled in a private Medicare plan. For all other payers, please reach out to the insurer for their billing and coverage policies.

In May 2021, the Department of Health and Human Services (HHS) launched the COVID-19 Coverage Assistance Fund (CAF) to cover the costs of administering COVID-19 vaccines to patients enrolled in health plans that either do not cover vaccination fees or cover them with patient cost-sharing. For more information on applying for these funds, refer to the CAF website.

Additional Resources

Payer Resources

Private payers continue to update their policies as the COVID-19 public health crisis. To check each payer’s most updated policy changes in relation to the billing and coding for telehealth and COVID-19, please visit the payer’s website.